↓ Skip to main content

The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial

Overview of attention for article published in Cardiovascular Diabetology, May 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial
Published in
Cardiovascular Diabetology, May 2018
DOI 10.1186/s12933-018-0709-9
Pubmed ID
Authors

Fiona J. Dore, Cleyton C. Domingues, Neeki Ahmadi, Nabanita Kundu, Yana Kropotova, Sara Houston, Carol Rouphael, Aytan Mammadova, Linda Witkin, Anamil Khiyami, Richard L. Amdur, Sabyasachi Sen

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 14 15%
Student > Master 11 12%
Researcher 9 10%
Student > Doctoral Student 5 5%
Student > Ph. D. Student 5 5%
Other 12 13%
Unknown 35 38%
Readers by discipline Count As %
Medicine and Dentistry 24 26%
Nursing and Health Professions 13 14%
Biochemistry, Genetics and Molecular Biology 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Immunology and Microbiology 1 1%
Other 3 3%
Unknown 37 41%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2018.
All research outputs
#17,948,821
of 23,047,237 outputs
Outputs from Cardiovascular Diabetology
#1,016
of 1,406 outputs
Outputs of similar age
#236,863
of 326,458 outputs
Outputs of similar age from Cardiovascular Diabetology
#23
of 29 outputs
Altmetric has tracked 23,047,237 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,406 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,458 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.